ANAVEX LIFE SCIENCES CORP. Current Assets
ANAVEX LIFE SCIENCES CORP. (AVXL) had Current Assets of $31.63 million as of 2020-06-30, per its 10-Q filed 2020-08-06.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2020-08-06
- 2020-06-30: Assets, Current $31.63M.
- 2019-09-30: Assets, Current $25.33M.
- 2019-06-30: Assets, Current $21.82M.
- 2019-03-31: Assets, Current $20.55M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2020-06-30 | $31.63M 10-Q · filed 2020-08-06 | |
| 2019-09-30 | $25.33M 10-Q · filed 2020-08-06 | |
| 2019-06-30 | $21.82M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $20.55M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $22.10M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $26.05M 10-K · filed 2019-12-16 | $24.32M 10-K · filed 2018-12-12 |
| 2018-06-30 | $26.74M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $25.81M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $28.29M 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $27.79M 10-K · filed 2019-01-25 | |
| 2017-06-30 | $24.85M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $23.55M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $21.32M 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $9.45M 10-K · filed 2017-12-11 | |
| 2016-06-30 | $9.84M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $12.11M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $14.02M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $15.47M 10-K · filed 2016-12-14 | |
| 2015-06-30 | $7.98M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $6.36M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $7.05M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $7.35M 10-K · filed 2015-12-29 | |
| 2014-06-30 | $8.20M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $9.22M 10-Q/A · filed 2014-05-30 | |
| 2013-12-31 | $148.75K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $393.45K 10-K · filed 2014-12-29 | |
| 2013-06-30 | $3.48K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $487.00 10-Q · filed 2013-05-17 | |
| 2012-12-31 | $79.79K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $12.58K 10-K · filed 2013-12-30 | |
| 2012-06-30 | $21.09K 10-Q · filed 2012-08-17 | |
| 2012-03-31 | $189.59K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $82.62K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $200.60K 10-K · filed 2012-12-31 | |
| 2011-06-30 | $1.28M 10-Q · filed 2011-08-12 | |
| 2010-09-30 | $325.76K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |